Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17564637 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells
Condition: Autoimmune Diseases
Intervention: Drug: Efalizumab

Study has passed its completion date and status has not been verified in more than two years.